Chromacity Secures £1 Million for Laser Innovations
Chromacity, a pioneering business based in Edinburgh, Scotland, has successfully raised over £1 million in funding to further its innovative laser technology initiatives. This significant financial backing came from notable investors, including Eos Advisory, Kelvin Capital, Scottish Enterprise, and the UK Government’s Innovate UK programme. With these funds, the company plans to propel the launch of its cutting-edge laser technology specifically designed for applications in the healthcare and agriculture sectors. This strategic move emphasizes Chromacity's commitment to harnessing the power of laser technology to address crucial challenges in these vital industries.
Under the capable leadership of CEO Julian Hayes, Chromacity excels in the design, development, and manufacturing of advanced pulsed fibre lasers.
The company has carved out a niche in producing fixed wavelength femtosecond fibre lasers and picosecond optical parametric oscillator (OPO) based tuneable laser systems. These innovations are built upon a unique patented laser architecture that guarantees ultra-stable performance over prolonged periods. The fixed wavelength femtosecond fibre lasers operate at critical wavelengths of 1040nm, 920nm, and 520nm, while the tuneable picosecond OPO lasers can be fine-tuned across a broad spectrum of near infrared and mid infrared wavelengths, ranging from 1.4um to 12um. This technological versatility positions Chromacity as a leader in the laser technology landscape.
The applications of Chromacity’s lasers are vast and significantly impact scientific and industrial research. These state-of-the-art lasers are utilized for a variety of purposes, including but not limited to spectroscopy for materials analysis, microscopy for biological imaging, defect detection, pollution monitoring, and an extensive range of quantum applications. The company has established a robust international customer base that includes prestigious organizations such as Sandia National Laboratories, Harvard University, and the US Air Force. These collaborations highlight Chromacity’s capability to provide essential tools that enable cutting-edge research and innovation across multiple fields, thus underscoring the critical role of advanced laser technology in our modern world.
They've invested in Chromacity
Get to know these Healthtech investors
Click here for a full list of 6,908+ startup investors in the UK